Broadly Reactive Antibodies Against Chimeric Virus-Host Antigens
针对嵌合病毒宿主抗原的广泛反应性抗体
基本信息
- 批准号:7984238
- 负责人:
- 金额:$ 57.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-14 至 2014-05-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAddressAntibodiesAntibody FormationAntigensAntiviral AgentsAntiviral ResponseB-LymphocytesBindingBiological AssayCell SeparationCell membraneCell physiologyCellsCellular StructuresClinicalCollaborationsDevelopmentEpitopesGlycoproteinsHIVHIV Envelope Protein gp120HIV InfectionsHIV vaccineHIV-1HumanImmune responseImmunityImmunologyIn VitroInfectionKnowledgeLaboratoriesLeadLipidsMapsMeasuresMediatingMembrane LipidsMethodsMonoclonal AntibodiesMusNeutralization TestsOutcomePeptide/MHC ComplexPeptidesProteinsRNA InterferenceResearchScreening procedureStructureSurfaceT-Cell ReceptorT-LymphocyteTechniquesTestingUniversitiesVaccinationVaccine ResearchVaccinesViralViral AntibodiesViral AntigensViral PhysiologyViral ProteinsVirionVirusVirus DiseasesVirus-like particleWorkanti-influenzabasedesignenv Glycoproteinsinfluenzavirusinhibiting antibodyinterestneutralizing antibodynovelnovel strategiesprevent
项目摘要
DESCRIPTION (provided by applicant):
HIV-1 buds off cell membranes and incorporates host proteins in its envelope. In this proposal, we address the impact these host proteins have on HIV immunity. We will test the hypothesis that during HIV infection, antibodies are made against epitopes formed partly by host proteins and partly by viral Env glycoproteins and that such antibodies have broad anti-viral activity. Thus, we propose the very novel concept that chimeric antigens, consisting of a stable or transient interface between host and viral components, are a feature of viral immunity. If our hypothesis is correct, immunogens could be made by combining viral proteins with conserved host proteins, thereby allowing a high proportion of conserved determinants. In addition, since chimeric antigens are likely to be conformational, unique immunogens based on conserved structures derived from host/virus interfaces could be constructed. We will accomplish the following specific aims: 1) Screen mAbs for binding to chimeric antigens. We will screen mAbs (from HIV-infected subjects) against virus-like particles (VLPs) or Env-expressing cells with or without host proteins known to occur on virion surfaces. Expression of host proteins will be regulated by RNA interference (RNAi). mAbs binding only to VLPs or cells expressing both Env and a host protein of interest will be evaluated further; 2) Determine the antiviral function of mAbs directed against chimeric antigens. Antibodies will be tested for neutralization and antibody-dependent cell-mediated virus inhibition against a panel of HIV-1 strains. Since we will screen as many as 1,000 mAbs and consider at least 20 host proteins as partners with Env in forming epitopes, we will have an excellent chance of finding chimeric antigens should they exist. Moreover, the extent of our screening will provide confidence in a negative result. Thus, our methods are designed to fully explore the hypothesis that antibodies against chimeric antigens occur during HIV infection, and we will gain strong evidence of their presence or absence. If successful, our research will result in a paradigm shift away from the concept that anti- viral antibody responses are always directed against uniquely viral epitopes and toward the decidedly new concept of epitopes made from virus plus host. Moreover, our novel concept of chimeric antigens may yield new, broadly anti-viral mAbs and novel immunogens that elicit broadly anti-viral responses. Discovering chimeric antigens could have a profound impact on HIV prevention by overcoming seemingly intractable obstacles to an effective vaccine. A major obstacle to the development of an HIV vaccine is the lack of an immunogen that elicits broadly anti- viral antibody responses. We propose an exceptionally novel approach to discover such immunogens. If successful, this research may lead directly to a vaccine that prevents HIV infection.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Donald N Forthal其他文献
Donald N Forthal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Donald N Forthal', 18)}}的其他基金
The role of antibody and the Fc neonatal receptor in transmitted/founder strain selection
抗体和 Fc 新生儿受体在传播/创始菌株选择中的作用
- 批准号:
9089719 - 财政年份:2015
- 资助金额:
$ 57.45万 - 项目类别:
The impact of antibody and pH on female-to-male SIV infection
抗体和pH值对女性对男性SIV感染的影响
- 批准号:
8688891 - 财政年份:2012
- 资助金额:
$ 57.45万 - 项目类别:
The impact of antibody and pH on female-to-male SIV infection
抗体和pH值对女性对男性SIV感染的影响
- 批准号:
8410404 - 财政年份:2012
- 资助金额:
$ 57.45万 - 项目类别:
The impact of antibody and pH on female-to-male SIV infection
抗体和pH值对女性对男性SIV感染的影响
- 批准号:
8876564 - 财政年份:2012
- 资助金额:
$ 57.45万 - 项目类别:
The impact of antibody and pH on female-to-male SIV infection
抗体和pH值对女性对男性SIV感染的影响
- 批准号:
8505379 - 财政年份:2012
- 资助金额:
$ 57.45万 - 项目类别:
Rodent Animal Biosafety Level 3 (ABSL3)
啮齿类动物生物安全 3 级 (ABSL3)
- 批准号:
8260272 - 财政年份:2011
- 资助金额:
$ 57.45万 - 项目类别:
PSWRCE Cpmprehensive Program Training Program for High Containment Lab
PSWRCE 高密闭实验室 CPM 综合项目培训计划
- 批准号:
8260273 - 财政年份:2011
- 资助金额:
$ 57.45万 - 项目类别:
Broadly Reactive Antibodies Against Chimeric Virus-Host Antigens
针对嵌合病毒宿主抗原的广泛反应性抗体
- 批准号:
8465819 - 财政年份:2010
- 资助金额:
$ 57.45万 - 项目类别:
Broadly Reactive Antibodies Against Chimeric Virus-Host Antigens
针对嵌合病毒宿主抗原的广泛反应性抗体
- 批准号:
8089308 - 财政年份:2010
- 资助金额:
$ 57.45万 - 项目类别:
Broadly Reactive Antibodies Against Chimeric Virus-Host Antigens
针对嵌合病毒宿主抗原的广泛反应性抗体
- 批准号:
8279451 - 财政年份:2010
- 资助金额:
$ 57.45万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 57.45万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 57.45万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 57.45万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 57.45万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 57.45万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 57.45万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 57.45万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 57.45万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 57.45万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 57.45万 - 项目类别:
Research Grant